If you need more lookups,
subscriptions start at $34 USD/month.
Adam Ismail Location
Salt Lake City, UT, US
Adam Ismail Work
2026 -now Interim co-CEO and Chief Commercial Officer @
2025 -2026 Chief Commercial Officer @
2024 -2025 Chief Business Officer @
2018 -2024 Chief Strategy Officer @
2018 -now Board Member @
2007 -2018 Executive Director @
2018 -2021 Board Member @ Acumen Health Holdings
1999 -2012 Columnist @ Nutraceuticals World Magazine
2004 -2007 Manager, Business Development @
1999 -2002 Senior Consultant @ Health Strategy Consulting
1999 -2002 Senior Consultant @
Adam Ismail Education
IESE Business School
MBA (Finance, Management)
2002-2004
Questrom School of Business, Boston University
BSBA (Finance, Organizational Behavior)
1995-1999
Adam Ismail Skills
Strategic Planning
Business Strategy
New Business Development
Marketing Strategy
Product Development
Business Development
Management
International Business
Strategic Partnerships
Food
Strategy
Marketing
Nutrition
Public Speaking
Mergers & Acquisitions
Cross-functional Team Leadership
Brand Management
Sales Management
Negotiation
Market Research
Competitive Analysis
Marketing Communications
Business Planning
Market Analysis
Marketing Management
Product Marketing
Start-ups
Entrepreneurship
Market Planning
Leadership
Girardin Logement Social
Cross Functional Team
Fip Isf
Start Ups
Cross Functional Team Leadership
Mergers and Acquisitions
Adam Ismail Summary
Adam Ismail, based in Salt Lake City, UT, US, is currently a Interim co-CEO and Chief Commercial Officer at KD Pharma Group. Adam Ismail brings experience from previous roles at KD Pharma Group and Global Organization for EPA and DHA Omega-3s. Adam Ismail holds a 2002 - 2004 MBA in Finance, Management @ IESE Business School. With a robust skill set that includes Strategic Planning, Business Strategy, New Business Development, Marketing Strategy, Product Development and more. Adam Ismail has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Adam Ismail?
Find contact details for 700 million professionals.